Cargando…
Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis
OBJECTIVE: Lupus nephritis (LN) is an immune complex-mediated glomerular and tubulointerstitial disease in patients with SLE. Prediction of outcomes at the onset of LN diagnosis can guide decisions regarding intensity of monitoring and therapy for treatment success. Currently, no machine learning mo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386213/ https://www.ncbi.nlm.nih.gov/pubmed/34429335 http://dx.doi.org/10.1136/lupus-2021-000489 |
_version_ | 1783742217234415616 |
---|---|
author | Helget, Lindsay N Dillon, David J Wolf, Bethany Parks, Laura P Self, Sally E Bruner, Evelyn T Oates, Evan E Oates, Jim C |
author_facet | Helget, Lindsay N Dillon, David J Wolf, Bethany Parks, Laura P Self, Sally E Bruner, Evelyn T Oates, Evan E Oates, Jim C |
author_sort | Helget, Lindsay N |
collection | PubMed |
description | OBJECTIVE: Lupus nephritis (LN) is an immune complex-mediated glomerular and tubulointerstitial disease in patients with SLE. Prediction of outcomes at the onset of LN diagnosis can guide decisions regarding intensity of monitoring and therapy for treatment success. Currently, no machine learning model of outcomes exists. Several outcomes modelling works have used univariate or linear modelling but were limited by the disease heterogeneity. We hypothesised that a combination of renal pathology results and routine clinical laboratory data could be used to develop and to cross-validate a clinically meaningful machine learning early decision support tool that predicts LN outcomes at approximately 1 year. METHODS: To address this hypothesis, patients with LN from a prospective longitudinal registry at the Medical University of South Carolina enrolled between 2003 and 2017 were identified if they had renal biopsies with International Society of Nephrology/Renal Pathology Society pathological classification. Clinical laboratory values at the time of diagnosis and outcome variables at approximately 1 year were recorded. Machine learning models were developed and cross-validated to predict suboptimal response. RESULTS: Five machine learning models predicted suboptimal response status in 10 times cross-validation with receiver operating characteristics area under the curve values >0.78. The most predictive variables were interstitial inflammation, interstitial fibrosis, activity score and chronicity score from renal pathology and urine protein-to-creatinine ratio, white blood cell count and haemoglobin from the clinical laboratories. A web-based tool was created for clinicians to enter these baseline clinical laboratory and histopathology variables to produce a probability score of suboptimal response. CONCLUSION: Given the heterogeneity of disease presentation in LN, it is important that risk prediction models incorporate several data elements. This report provides for the first time a clinical proof-of-concept tool that uses the five most predictive models and simplifies understanding of them through a web-based application. |
format | Online Article Text |
id | pubmed-8386213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-83862132021-09-09 Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis Helget, Lindsay N Dillon, David J Wolf, Bethany Parks, Laura P Self, Sally E Bruner, Evelyn T Oates, Evan E Oates, Jim C Lupus Sci Med Lupus Nephritis OBJECTIVE: Lupus nephritis (LN) is an immune complex-mediated glomerular and tubulointerstitial disease in patients with SLE. Prediction of outcomes at the onset of LN diagnosis can guide decisions regarding intensity of monitoring and therapy for treatment success. Currently, no machine learning model of outcomes exists. Several outcomes modelling works have used univariate or linear modelling but were limited by the disease heterogeneity. We hypothesised that a combination of renal pathology results and routine clinical laboratory data could be used to develop and to cross-validate a clinically meaningful machine learning early decision support tool that predicts LN outcomes at approximately 1 year. METHODS: To address this hypothesis, patients with LN from a prospective longitudinal registry at the Medical University of South Carolina enrolled between 2003 and 2017 were identified if they had renal biopsies with International Society of Nephrology/Renal Pathology Society pathological classification. Clinical laboratory values at the time of diagnosis and outcome variables at approximately 1 year were recorded. Machine learning models were developed and cross-validated to predict suboptimal response. RESULTS: Five machine learning models predicted suboptimal response status in 10 times cross-validation with receiver operating characteristics area under the curve values >0.78. The most predictive variables were interstitial inflammation, interstitial fibrosis, activity score and chronicity score from renal pathology and urine protein-to-creatinine ratio, white blood cell count and haemoglobin from the clinical laboratories. A web-based tool was created for clinicians to enter these baseline clinical laboratory and histopathology variables to produce a probability score of suboptimal response. CONCLUSION: Given the heterogeneity of disease presentation in LN, it is important that risk prediction models incorporate several data elements. This report provides for the first time a clinical proof-of-concept tool that uses the five most predictive models and simplifies understanding of them through a web-based application. BMJ Publishing Group 2021-08-24 /pmc/articles/PMC8386213/ /pubmed/34429335 http://dx.doi.org/10.1136/lupus-2021-000489 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Lupus Nephritis Helget, Lindsay N Dillon, David J Wolf, Bethany Parks, Laura P Self, Sally E Bruner, Evelyn T Oates, Evan E Oates, Jim C Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis |
title | Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis |
title_full | Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis |
title_fullStr | Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis |
title_full_unstemmed | Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis |
title_short | Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis |
title_sort | development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis |
topic | Lupus Nephritis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386213/ https://www.ncbi.nlm.nih.gov/pubmed/34429335 http://dx.doi.org/10.1136/lupus-2021-000489 |
work_keys_str_mv | AT helgetlindsayn developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis AT dillondavidj developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis AT wolfbethany developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis AT parkslaurap developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis AT selfsallye developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis AT brunerevelynt developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis AT oatesevane developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis AT oatesjimc developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis |